Axiom Investors LLC Lantheus Holdings, Inc. Transaction History

Axiom Investors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $833,473 - $1.25 Million	-13,829 Reduced 29.13%	33,640 $2.34 Million
Q2 2023 Aug 10, 2023	SELL	$82.41 - $99.65 $1.93 Million - $2.34 Million	-23,441 Reduced 33.06%	47,469 $3.98 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $955,438 - $1.66 Million	20,005 Added 39.3%	70,910 $5.85 Million
Q4 2022 Feb 09, 2023	SELL	$48.76 - $77.67 $5.03 Million - $8.02 Million	-103,250 Reduced 66.98%	50,905 $2.59 Million
Q3 2022 Nov 10, 2022	BUY	$61.42 - $86.29 $2.78 Million - $3.91 Million	45,315 Added 41.63%	154,155 $10.8 Million
Q2 2022 Aug 11, 2022	BUY	$55.54 - $72.65 $1.05 Million - $1.38 Million	18,935 Added 21.06%	108,840 $7.19 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $2.18 Million - $5.09 Million	89,905 New	89,905 $4.97 Million

509

67.3M

1.19M

837K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.52B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.